EXOZ
Exozymes (EXOZ)
NASDAQ
$6.48+$0.17 (+2.75%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $58.5M
    Market Cap
  • -49.18%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
VANGUARD CAPITAL MANAGEMENT LLC
0.59%
54,985
+32,795 (+59.64%)
Jun 30, 2026
DAVIDSON KAHN CAPITAL MANAGEMENT, LLC
0.27%
25,000
+25,000 (+100.00%)
Jun 30, 2026
GEODE CAPITAL MANAGEMENT, LLC
0.25%
23,406
+1,515 (+6.47%)
Jun 30, 2026
N/A
0.24%
22,190
+22,190 (+100.00%)
Mar 31, 2026
BLACKROCK, INC.
0.10%
9,610
+2,813 (+29.27%)
Jun 30, 2026
VANGUARD FIDUCIARY TRUST CO
0.10%
9,426
0 (0.00%)
Jun 30, 2026
MORGAN STANLEY
0.01%
1,250
0 (0.00%)
Jun 30, 2026

Current Ownership Distribution

  • Other7.4M (79.90%)
  • Insiders1.5M (16.58%)
  • Institutions209,639 (2.26%)
  • Mutual Funds117,162 (1.26%)

Insider Transactions

  • 16.58% (1.5M)
    Current InsiderOwnership (%, shares)
  • 1
    Number of InsiderBuying (last 12 months)
  • $534,452.73
    Amount of InsiderBuying (last 12 months)
  • 1
    Number of InsiderSelling (last 12 months)
  • $15.0M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Heltzen Michael
Chief Executive Officer
Buy
Aug 26, 2026
$30.32
4
$7.58
14,708
Heltzen Michael
Chief Executive Officer
Buy
Aug 26, 2026
$1,844.85
251
$7.35
14,704
Heltzen Michael
Chief Executive Officer
Buy
Aug 26, 2026
$1,900.00
250
$7.60
14,453
Heltzen Michael
Chief Executive Officer
Buy
Aug 25, 2026
$1,880.00
250
$7.52
14,203
Heltzen Michael
Chief Executive Officer
Buy
Aug 25, 2026
$750.00
100
$7.50
13,953
Korman Tyler Paz
Chief Scientific Officer
Exempt
Aug 19, 2026
$0.00
32,964
$0.00
46,140
Perriman Damien Alan
Chief Commercial Officer
Exempt
Aug 19, 2026
$0.00
19,612
$0.00
43,147
Korman Tyler Paz
Chief Scientific Officer
Exempt
Aug 19, 2026
$0.00
32,964
$0.00
762,837
Heltzen Michael
Chief Executive Officer
Award
Aug 19, 2026
$56,582.40
8,841
$6.40
13,853
Perriman Damien Alan
Chief Commercial Officer
Exempt
Aug 19, 2026
$0.00
19,612
$0.00
28,499
Korman Tyler Paz
Chief Scientific Officer
Sell
Apr 09, 2026
$7,893.75
750
$10.53
729,123
Korman Tyler Paz
Chief Scientific Officer
Sell
Apr 08, 2026
$7,530.45
750
$10.04
729,873
Perriman Damien Alan
Chief Commercial Officer
Award
Apr 01, 2026
$0.00
146,437
$0.00
146,437
Perriman Damien Alan
Chief Commercial Officer
Award
Apr 01, 2026
$75,006.28
8,887
$8.44
0
Nawaz Fouad
Vice President- Finance
Award
Apr 01, 2026
$50,631.56
5,999
$8.44
9,488
Opgenorth Paul Hideo
Vice President, Development
Award
Apr 01, 2026
$33,751.56
3,999
$8.44
645,149
Perriman Damien Alan
Chief Commercial Officer
Award
Apr 01, 2026
$0.00
62,759
$0.00
62,759
Heltzen Michael
Chief Executive Officer
Buy
Jul 02, 2025
$10,628.80
1,040
$10.22
10,629
Korman Tyler Paz
Vice President, Research
Award
Jun 16, 2025
$37,494.60
2,990
$12.54
725,291
Nawaz Fouad
Vice President, Finance
Award
Jun 13, 2025
$43,752.06
3,489
$12.54
3,489
Opgenorth Paul Hideo
Vice President, Development
Award
Jun 13, 2025
$37,494.60
2,990
$12.54
641,150
Heltzen Michael
Chief Executive Officer
Buy
Jan 17, 2025
$19,048.26
1,767
$10.78
3,872
Heltzen Michael
Chief Executive Officer
Buy
Jan 16, 2025
$1,297.12
121
$10.72
2,105
Heltzen Michael
Chief Executive Officer
Buy
Nov 15, 2024
$22,022.40
1,984
$11.10
1,984
Heltzen Michael
Chief Executive Officer
Buy
Nov 15, 2024
$22,022.40
1,984
$11.10
1,984
MDB Capital Holdings, LLC
Conversion
Nov 08, 2024
$785,004.80
122,657
$6.40
3.9M
Opgenorth Paul Hideo
Vice President, Development
Conversion
Nov 08, 2024
$15,001.60
2,344
$6.40
640,504
Opgenorth Paul Hideo
Vice President, Development
Conversion
Nov 08, 2024
$15,001.60
2,344
$6.40
640,504